At Decibel, we are exclusively focused on discovering and developing transformative treatments to restore and improve hearing and balance. We have assembled a highly experienced scientific team and built a unique platform to achieve this goal.

We Are:

Scientists working at the cutting edge of inner ear biology, genetics and genomics, bioinformatics, gene therapy, and drug delivery

Drug developers with deep expertise in pharmacology, translational medicine, and manufacturing, who have filed more than 45 INDs and launched 17 therapies

Clinicians who have spent years treating hearing and balance disorders and are applying their expertise to clinical development

Entrepreneurs who have raised more than $5.5 billion in capital and successfully executed 4 IPOs

Our Leadership

Geoff Horwitz
Adrian Timmers

Board of Directors


We actively seek additional partnerships and in-licensing opportunities. If you would like to discuss an opportunity with Decibel, please contact